Monte Rosa Therapeutics, Inc.

NASDAQ:GLUE

7.05 (USD) • At close December 24, 2024
Overview | Financials

Numbers are in millions (except for per share data and ratios) USD.

2024 Q32024 Q22024 Q12023 Q42023 Q32023 Q22023 Q12022 Q42022 Q32022 Q22022 Q12021 Q42021 Q32021 Q22021 Q12020 Q42020 Q32020 Q22020 Q1
Operating Activities:
Net Income -23.859-30.31-31.968-33.252-34.884-35.178-32.038-30.782-27.318-26.469-23.932-23.44-19.837-18.405-12.276-19.656-6.557-5.364-4.302
Depreciation & Amortization 2.1032.061.8971.8461.8341.3911.1511.071.0330.8890.7530.8090.5820.4670.2740.2230.1710.0720.071
Deferred Income Tax 000-1.998000000000000-0.00100
Stock Based Compensation 4.2824.5024.8734.0744.4684.1533.9743.3263.2142.8732.2511.8562.0731.0190.2520.2010.0450.0970.011
Change In Working Capital 15.823-2.925-12.89857.7034.3735.7484.6422.0731.2661.212-6.6856.599-0.6253.337-3.0252.978-0.550.9830.844
Accounts Receivables 8.91-9.327-0.01-00.375-0.1952.053-0-00000000000
Change In Inventory 0000-0.3750.195-2.053000000000000
Change In Accounts Payables -2.380.394-5.075.7680.686-1.0020.3060.1551.648-0.363-2.1844.74-4.251-0.289-0.9061.929-0.6521.9840.174
Other Working Capital 9.2936.008-7.81851.9353.6876.754.3361.918-0.3821.575-4.5011.8593.6263.626-2.1191.0490.102-1.0010.67
Other Non Cash Items -19.34316.46113.6781.261-0.497-1.438-1.1350.3521.2050.9940.2090.0040.0132.2420.967.680.0011.9840.174
Operating Cash Flow -20.994-27.767-38.16529.634-24.706-25.324-23.406-23.961-20.6-20.501-27.404-14.172-17.794-13.582-13.815-8.574-6.891-4.212-3.376
Investing Activities:
Investments In Property Plant And Equipment -0.399-2.022-1.384-1.689-1.659-6.512-9.181-7.271-1.4-2.553-1.687-3.059-1.755-2.701-2.217-1.186-0.93-1.26-0.013
Acquisitions Net 000-0.016-0.0370.0620.1310.047-0.0160.0120.1250.0120.067000000
Purchases Of Investments -32.373-73.959-56.068-27.514-7.813-0.062-67.824-94.368-59.395-51.696-178.95800000000
Sales Maturities Of Investments 70.52114.82367.30543.545.12597.33147.790.340000000000
Other Investing Activites 0-59.13611.2370.0160.0370.062-0.131-0.0470.031-0.0120.1250.0120.067000000
Investing Cash Flow 37.749-61.1589.85314.29735.62818.5520.326-53.93929.489-14.249-180.52-3.047-1.688-2.701-2.217-1.186-0.93-1.26-0.013
Financing Activities:
Debt Repayment 0000000000000000000
Common Stock Issued 098.0230.24625.1731.1011.20.01820.055-0.2170.0960.153-0.13531.0110142.7690000
Common Stock Repurchased 000000000000.23100-0.23100-0.1780
Dividends Paid 0000000000000000000
Other Financing Activities 0.65698.0230.24625.1731.1011.20.0180.379-0.2170.0960.153-0.135-1.555205.472142.769-0.0147.74812.3220
Financing Cash Flow 0.01598.0230.24625.1731.1011.20.01820.434-0.2170.0960.153-0.13529.456205.472142.769-0.0147.74812.3220
Other Information:
Effect Of Forex Changes On Cash 000-0.058000000000000000
Net Change In Cash 16.779.095-28.34969.04612.023-5.574-3.062-57.4668.672-34.654-207.771-17.3549.974189.189126.737-9.7739.9276.85-3.389
Cash At End Of Period 130.483108.84799.752128.10163.57751.55457.12860.19117.656108.984143.638351.409368.763358.789169.642.86352.63312.7065.856